0001127602-13-010792.txt : 20130314 0001127602-13-010792.hdr.sgml : 20130314 20130314161506 ACCESSION NUMBER: 0001127602-13-010792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130312 FILED AS OF DATE: 20130314 DATE AS OF CHANGE: 20130314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 13690664 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 2696738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-03-12 0000820096 PERRIGO CO PRGO 0001242215 PAPA JOSEPH C C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN MI 49010 1 1 1 President and CEO Chairman Common Stock 2013-03-12 4 S 0 10000 116.0945 D 105645 D Common Stock 2013-03-12 4 M 0 5000 30.06 A 110645 D Common Stock 2013-03-12 4 S 0 3000 116.3295 D 107645 D Common Stock 2013-03-12 4 S 0 2000 117.5043 D 105645 D Employee Stock Option Right to Buy 30.06 2013-03-12 4 M 0 5000 0 D 2010-08-25 2019-08-25 Common Stock 5000 7186 D This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 8, 2012. This 10b5-1 sales plan will expire on the close of business November 8, 2013. The price in column 4 is a weighted average. The prices actually received ranged from $115.63 to $116.49. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $116.06 to $116.75. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $117.30 to $117.65. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. /s/ Penny Bursma, Attorney-in-fact for Joseph C. Papa 2013-03-14